secwatch.observer — SEC 8-K summary
======================================

Issuer:     AbbVie Inc. (ABBV)
CIK:        0001551152
Form:       8-K
Filed at:   2023-03-28T23:59:59+00:00
Accession:  0001104659-23-037749
Event type: debt
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AbbVie amends revolver: commitments raised to $5.0B, maturity extended to 2028
------------------------------------------------------------------------------

- Revolving credit facility commitments increased from $4.0B to $5.0B.
- Maturity date extended from August 27, 2024 to March 28, 2028.
- Facility remains unsecured; JPMorgan Chase continues as administrative agent.
- Second Amended and Restated Revolving Credit Agreement dated March 28, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1551152/000110465923037749/0001104659-23-037749-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1551152/000110465923037749/tm2310687d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-037749

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer